Last updated on: 11/3/2011 | Author:

Mikkel Arendt, MSCPsych, PhD Biography

Researcher in the Unit for Psychiatric Research at Aalborg Psychiatric Hospital
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“The risk of schizophrenia after a cannabis-induced psychosis is independent of familial predisposition… Cannabis-induced psychosis may be an early marker of schizophrenia… Psychotic symptoms after cannabis use should be taken extremely seriously.”

“Familial Predisposition for Psychiatric Disorder: Comparison of Subjects Treated for Cannabis-Induced Psychosis and Schizophrenia,” Archives of General Psychiatry, 2008

Theoretical Expertise Ranking:
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
Involvement and Affiliations:
  • Researcher, Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital (Denmark)
  • Member, European Psychiatric Association, 2011
  • Lecturer, “Cannabis and Psychosis,” Aalborg Psychiatric Summer School, 2010
  • Visiting Researcher, Columbia University, 2006 and 2009
  • Lecturer, “Cannabis Use and Psychotic Symptoms,” Aalborg Psychiatric Hospital, 2008
  • PhD, Health Sciences, University of Aarhus, 2006
  • MSCPsych, Psychology, University of Aarhus, 2001
  • Dr. Arendt’s research is primarily focused on the relationship between cannabis use and psychiatric disorders, but he has also published original research on PTSD, panic disorder, depression, bipolar disorder, and schizophrenia.